Selventa and Rosa plan to combine knowledge assets, proprietary data, physiologic model libraries, and expertise in several disease areas with the aim of helping clients make better drug discovery and development decisions.
The two firms' combined modeling and analysis will integrate genomic, transcriptomic, in vitro, animal, and clinical data in a quantitative model.
Jeremy Berg is stepping down from NIGMS, Timothy Triche is named to Wafergen's scientific advisory board, and Uwe Neue has died.
The company said it will focus on providing consulting services and software, and help its clients select patient-specific treatments.
The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.
In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.